Literature DB >> 21647293

Investigating the purpose of prelamin A processing.

Brandon Sj Davies1, Catherine Coffinier, Shao H Yang, Richard H Barnes, Hea-Jin Jung, Stephen G Young, Loren G Fong.   

Abstract

Lmna yields two major protein products in somatic cells, lamin C and prelamin A. Mature lamin A is produced from prelamin A by four posttranslational processing steps-farnesylation of a carboxyl-terminal cysteine, release of the last three amino acids of the protein, methylation of the farnesylcysteine, and the endoproteolytic release of the carboxyl-terminal 15 amino acids of the protein (including the farnesylcysteine methyl ester). Although the posttranslational processing of prelamin A has been conserved in vertebrate evolution, its physiologic significance remains unclear. Here we review recent studies in which we investigated prelamin A processing with Lmna knock-in mice that produce exclusively prelamin A (Lmna(PLAO)), mature lamin A (Lmna(LAO)) or nonfarnesylated prelamin A (Lmna(nPLAO)). We found that the synthesis of lamin C is dispensable in laboratory mice, that the direct production of mature lamin A (completely bypassing all prelamin A processing) causes no discernable pathology in mice, and that exclusive production of nonfarnesylated prelamin A leads to cardiomyopathy.

Entities:  

Keywords:  cardiomyopathy; prelamin A; progeria; protein farnesylation; restrictive dermopathy

Mesh:

Substances:

Year:  2011        PMID: 21647293      PMCID: PMC3104803          DOI: 10.4161/nucl.2.1.13723

Source DB:  PubMed          Journal:  Nucleus        ISSN: 1949-1034            Impact factor:   4.197


  52 in total

Review 1.  Protein isoprenylation and methylation at carboxyl-terminal cysteine residues.

Authors:  S Clarke
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 2.  The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature.

Authors:  F L DeBusk
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

3.  Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.

Authors:  Brian C Capell; Michael R Erdos; James P Madigan; James J Fiordalisi; Renee Varga; Karen N Conneely; Leslie B Gordon; Channing J Der; Adrienne D Cox; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

4.  Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice.

Authors:  Alberto M Pendás; Zhongjun Zhou; Juan Cadiñanos; José M P Freije; Jianming Wang; Kjell Hultenby; Aurora Astudillo; Annika Wernerson; Francisco Rodríguez; Karl Tryggvason; Carlos López-Otín
Journal:  Nat Genet       Date:  2002-04-01       Impact factor: 38.330

5.  A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.

Authors:  Shao H Yang; Margarita Meta; Xin Qiao; David Frost; Joy Bauch; Catherine Coffinier; Sharmila Majumdar; Martin O Bergo; Stephen G Young; Loren G Fong
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

6.  Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation.

Authors:  Shao H Yang; Xin Qiao; Loren G Fong; Stephen G Young
Journal:  Biochim Biophys Acta       Date:  2007-11-26

7.  Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytes.

Authors:  Roger Lee; Sandy Y Chang; Hung Trinh; Yiping Tu; Andrew C White; Brandon S J Davies; Martin O Bergo; Loren G Fong; William E Lowry; Stephen G Young
Journal:  Hum Mol Genet       Date:  2010-01-27       Impact factor: 6.150

8.  Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy.

Authors:  T Sullivan; D Escalante-Alcalde; H Bhatt; M Anver; N Bhat; K Nagashima; C L Stewart; B Burke
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

9.  Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria.

Authors:  Shao H Yang; Sandy Y Chang; Douglas A Andres; H Peter Spielmann; Stephen G Young; Loren G Fong
Journal:  J Lipid Res       Date:  2009-10-26       Impact factor: 5.922

10.  Incorporation of a product of mevalonic acid metabolism into proteins of Chinese hamster ovary cell nuclei.

Authors:  L A Beck; T J Hosick; M Sinensky
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

View more
  27 in total

Review 1.  Lamins at a glance.

Authors:  Chin Yee Ho; Jan Lammerding
Journal:  J Cell Sci       Date:  2012-05-01       Impact factor: 5.285

2.  An absence of nuclear lamins in keratinocytes leads to ichthyosis, defective epidermal barrier function, and intrusion of nuclear membranes and endoplasmic reticulum into the nuclear chromatin.

Authors:  Hea-Jin Jung; Angelica Tatar; Yiping Tu; Chika Nobumori; Shao H Yang; Chris N Goulbourne; Harald Herrmann; Loren G Fong; Stephen G Young
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

Review 3.  Nuclear lamins and neurobiology.

Authors:  Stephen G Young; Hea-Jin Jung; John M Lee; Loren G Fong
Journal:  Mol Cell Biol       Date:  2014-05-19       Impact factor: 4.272

Review 4.  Mitogen-activated protein kinase inhibitor regulation of heart function and fibrosis in cardiomyopathy caused by lamin A/C gene mutation.

Authors:  Antoine Muchir; Wei Wu; Howard J Worman
Journal:  Trends Cardiovasc Med       Date:  2010-10       Impact factor: 6.677

Review 5.  Nuclear lamina at the crossroads of the cytoplasm and nucleus.

Authors:  Larry Gerace; Michael D Huber
Journal:  J Struct Biol       Date:  2011-11-22       Impact factor: 2.867

6.  Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins.

Authors:  Yuexia Wang; Cecilia Ostlund; Jason C Choi; Theresa C Swayne; Gregg G Gundersen; Howard J Worman
Journal:  Nucleus       Date:  2012-08-16       Impact factor: 4.197

7.  A truncated lamin A in the Lmna -/- mouse line: implications for the understanding of laminopathies.

Authors:  Daniel Jahn; Sabine Schramm; Martina Schnölzer; Clemens J Heilmann; Chris G de Koster; Wolfgang Schütz; Ricardo Benavente; Manfred Alsheimer
Journal:  Nucleus       Date:  2012-08-16       Impact factor: 4.197

Review 8.  When lamins go bad: nuclear structure and disease.

Authors:  Katherine H Schreiber; Brian K Kennedy
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

Review 9.  Nuclear lamins in the brain - new insights into function and regulation.

Authors:  Hea-Jin Jung; John M Lee; Shao H Yang; Stephen G Young; Loren G Fong
Journal:  Mol Neurobiol       Date:  2012-10-14       Impact factor: 5.590

10.  Calcium causes a conformational change in lamin A tail domain that promotes farnesyl-mediated membrane association.

Authors:  Agnieszka Kalinowski; Zhao Qin; Kelli Coffey; Ravi Kodali; Markus J Buehler; Mathias Lösche; Kris Noel Dahl
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.